Sodium p-aminohippurate

• Diagnostic aids

• Aminohippurate Sodium
• Aminohippuric acid
• Aminohippuric acid Sodium salt
• Sodium p-aminohippurate

• No information avaliable

C₉H₁₀N₂O₃

http://www.rxlist.com/cgi/generic2/aminohippurate.htm

Sodium_p-aminohippurate MSDS

No information avaliable

194.187 g/mol

199-200 ^oC

Slightly soluble

Solid

-0.052

Solution for injection (1g drug per 5mL solution)

Used to measure effective renal plasma flow (ERPF) and to determine the functional capacity of the tubular excretory mechanism.

Aminohippurate (p-aminohippuric acid, PAH, PAHA) is the glycine amide of p-aminobenzoic acid. It is filtered by the glomeruli and is actively secreted by the proximal tubules. At low plasma concentrations (1.0 to 2.0 mg/100 mL), an average of 90 percent of aminohippurate is cleared by the kidneys from the renal blood stream in a single circulation. It is ideally suited for measurement of ERPF since it has a high clearance, is essentially nontoxic at the plasma concentrations reached with recommended doses, and its analytical determination is relatively simple and accurate. Aminohippurate is also used to measure the functional capacity of the renal tubular secretory mechanism or transport maximum (Tm_PAH). This is accomplished by elevating the plasma concentration to levels (40-60 mg/100 mL) sufficient to saturate the maximal capacity of the tubular cells to secrete aminohippurate. Inulin clearance is generally measured during Tm_PAH determinations since glomerular filtration rate (GFR) must be known before calculations of secretory Tm measurements can be done.

No information avaliable

No information avaliable

Humans and other mammals